Cited by

• A bibliometric and visualized research on global trends of immune checkpoint inhibitors related complications in melanoma, 2011-2021.

  Zhang H, Shi Y, Ying J, Chen Y, Guo R, Zhao X, Jia L, Xiong J, Jiang F. Zhang H, et al. Front Endocrinol (Lausanne). 2023 Apr 20;14:1164692. doi: 10.3389/fendo.2023.1164692. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37152956 Free PMC article.
• Delayed Effect of Dendritic Cells Vaccination on Survival in Glioblastoma: A Systematic Review and Meta-Analysis.

  Cozzi S, Najafi M, Gomar M, Ciammella P, Iotti C, Iaccarino C, Dominici M, Pavesi G, Chiavelli C, Kazemian A, Jahanbakhshi A. Cozzi S, et al. Curr Oncol. 2022 Feb 4;29(2):881-891. doi: 10.3390/curroncol29020075. Curr Oncol. 2022. PMID: 35200574 Free PMC article. Review.
• Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models.

  Grees M, Sharbi-Yunger A, Evangelou C, Baumann D, Cafri G, Tzehoval E, Eichmüller SB, Offringa R, Utikal J, Eisenbach L, Umansky V. Grees M, et al. Oncoimmunology. 2018 Mar 26;7(7):e1445457. doi: 10.1080/2162402X.2018.1445457. eCollection 2018. Oncoimmunology. 2018. PMID: 29900058 Free PMC article.
• Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance.

  Ahmed F, Haass NK. Ahmed F, et al. Front Oncol. 2018 May 24;8:173. doi: 10.3389/fonc.2018.00173. eCollection 2018. Front Oncol. 2018. PMID: 29881716 Free PMC article. Review.
• The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma Progression.

  Pan W, Zhu S, Qu K, Meeth K, Cheng J, He K, Ma H, Liao Y, Wen X, Roden C, Tobiasova Z, Wei Z, Zhao J, Liu J, Zheng J, Guo B, Khan SA, Bosenberg M, Flavell RA, Lu J. Pan W, et al. Immunity. 2017 Aug 15;47(2):284-297.e5. doi: 10.1016/j.immuni.2017.07.020. Immunity. 2017. PMID: 28813659 Free PMC article.